[ Price : $8.95]
Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions animal drug applications ap...[ Price : $8.95]
Boehringer Ingelheim reports data from its Phase 2 survodutide study showing that up to 83.0% of adults treated with the drug achi...[ Price : $8.95]
FDA approves Alvotech and Teva Pharmaceuticals Simlandi (adalimumab-ryvk) injection, an interchangeable biosimilar to AbbVies Humi...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Janssen Biotechs Rybrevant ...[ Price : $8.95]
FDA creates a new CARES Act Amount Information Reporting application for drug establishments to use when submitting (xxx insert, d...[ Price : $8.95]
New York attorney general Letitia James urges FDA to take further safety actions to address the dangers of Mercks Singilair (monte...[ Price : $8.95]
BrainStorm Cell Therapeutics files a Special Protocol Assessment request for a Phase 3b study of NurOwn, its investigational treat...[ Price : $8.95]
FDA accepts for priority review a Sanofi and Regeneron supplemental BLA for Dupixent (dupilumab) as an add-on maintenance treatmen...